skip to content
series

The Role of Reliable Diagnostics

PatientsInfectious diseases
Decorative illustration

Part of series

Voices against dengue
View series overview

The experience of individuals affected by Dengue highlights the critical need for reliable and accessible diagnostic tools. Early and accurate diagnosis is vital for confirming a Dengue infection and starting adequate treatment to help patients recover.

Dengue fever continues to pose significant health challenges worldwide, especially for travelers returning from endemic regions.

A Traveler's Tale: Dengue Misdiagnosis Abroad

Marcel’s experience with dengue during a trip to Thailand illustrates the often underestimated severity and complexity of this disease.

Photo of Marcel in Thailand
Marcel in Thailand before he caught Dengue

Marcel’s illness began with symptoms easily mistaken for the flu - a blocked nose and mild headache - leading him to self-medicate with ibuprofen, which is contraindicated in dengue cases due to increased bleeding risk.

His condition worsened on the flight back to Switzerland, culminating in a high fever of 41°C, a spreading rash, and intense fatigue. Despite visiting a doctor, the initial misdiagnosis as measles delayed proper testing and confirmation of dengue, highlighting the diagnostic challenges in countries where dengue is rare and healthcare providers may lack experience with the disease.

This virus is very rare in Switzerland and the lab only ran tests twice a week. I had missed the first round of the week and therefore the results only came back almost a week after with a positive result, of course.

Marcel Hodel

Dengue patient

Marcel’s story is a powerful reminder of the necessity for improved diagnostic and awareness in non-endemic regions, and continued vigilance in prevention efforts.

Brazil's Dengue Epidemic: Denise's Call for Action

Denise from Brazil, became one of the millions affected by dengue during the country’s historic 2024 outbreak. Her personal journey underscores the critical importance of reliable diagnostics and disease notification in managing public health crises.

In 2010, while working in a clinical laboratory, Denise began experiencing symptoms that initially seemed manageable with over-the-counter medication. However, her condition quickly deteriorated: she struggled to stand, suffered persistent malaise, and could not keep food down. Seeking hospital care, she underwent a blood count test that revealed a low platelet count, a key indicator of dengue disease. Denise was not tested with any specific tests for dengue diagnosis.

Brazil’s 2024 dengue epidemic was the worst on record, with over 6 million confirmed cases and a significant number of deaths1,2,3,4. Reliable diagnostics, such as serological tests and molecular assays, are essential for several reasons, including accurate diagnosis, epidemiological reporting and targeted Public Health response.

Denise’s story illustrates the consequences of underdiagnosis and underreporting. She now advocates for the routine use of serological tests and mandatory notification to ensure that every case contributes to a clearer understanding of the epidemic and a more effective response.

Photo of Denise

References

  1. Hackett D. São Paulo's Dengue Outbreak Setting New Records. [Internet; cited 2025 April 8]. Available from: https://www.vax-before-travel.com/2025/04/08/s-o-paulos-dengue-outbreak-setting-new-records

  2. World Mosquito Program. Global Progress in Brazil. [Internet; cited 2025 May 21]. Available from: https://www.worldmosquitoprogram.org/en/global-progress/brazil

  3. MedCrave Online. Reported cases of dengue in Brazil from 2015 to 2024. [Internet; cited 2025 May 21]. Available from: https://medcraveonline.com/MOJPH/MOJPH-14-00478.pdf

  4. Souza CDF, Nascimento RPS, Bezerra-Santos M, Armstrong ADC, Gomes OV, Nicácio JM, Júnior JVJS, Carmo RFD. Space-time dynamics of the dengue epidemic in Brazil, 2024: an insight for decision making. BMC Infect Dis. 2024 Sep 27;24(1):1056. doi: 10.1186/s12879-024-09813-z. PMID: 39333905; PMCID: PMC11430439.